94 related articles for article (PubMed ID: 17475713)
1. Cross-Platform Identification and Validation of Uveal Melanoma Vitreous Protein Biomarkers.
Velez G; Wolf J; Dufour A; Mruthyunjaya P; Mahajan VB
Invest Ophthalmol Vis Sci; 2023 Nov; 64(14):14. PubMed ID: 37955612
[TBL] [Abstract][Full Text] [Related]
2. Dual role of autotaxin as novel biomarker and therapeutic target in pancreatic neuroendocrine neoplasms.
Toyohara T; Yoshida M; Miyabe K; Hayashi K; Naitoh I; Kondo H; Hori Y; Kato A; Kachi K; Asano G; Sahashi H; Adachi A; Kuno K; Kito Y; Matsuo Y; Kataoka H
Cancer Sci; 2023 Dec; 114(12):4571-4582. PubMed ID: 37770812
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia Increases ATX Expression by Histone Crotonylation in a HIF-2α-Dependent Manner.
Qu M; Long Y; Wang Y; Yin N; Zhang X; Zhang J
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108194
[TBL] [Abstract][Full Text] [Related]
4. Multi-Modal Mass Spectrometric Imaging of Uveal Melanoma.
Cole LM; Handley J; Claude E; Duckett CJ; Mudhar HS; Sisley K; Clench MR
Metabolites; 2021 Aug; 11(8):. PubMed ID: 34436501
[TBL] [Abstract][Full Text] [Related]
5. BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas.
Field MG; Kuznetsov JN; Bussies PL; Cai LZ; Alawa KA; Decatur CL; Kurtenbach S; Harbour JW
Clin Cancer Res; 2019 Sep; 25(18):5663-5673. PubMed ID: 31285370
[TBL] [Abstract][Full Text] [Related]
6. Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities.
Rabbie R; Ferguson P; Molina-Aguilar C; Adams DJ; Robles-Espinoza CD
J Pathol; 2019 Apr; 247(5):539-551. PubMed ID: 30511391
[TBL] [Abstract][Full Text] [Related]
7. Are Risk Factors for Growth of Choroidal Nevi Associated With Malignant Transformation? Assessment With a Validated Genomic Biomarker.
Harbour JW; Paez-Escamilla M; Cai L; Walter SD; Augsburger JJ; Correa ZM
Am J Ophthalmol; 2019 Jan; 197():168-179. PubMed ID: 30195895
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Implications of Tumor Diameter in Association With Gene Expression Profile for Uveal Melanoma.
Walter SD; Chao DL; Feuer W; Schiffman J; Char DH; Harbour JW
JAMA Ophthalmol; 2016 Jul; 134(7):734-40. PubMed ID: 27123792
[TBL] [Abstract][Full Text] [Related]
9. Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.
Decatur CL; Ong E; Garg N; Anbunathan H; Bowcock AM; Field MG; Harbour JW
JAMA Ophthalmol; 2016 Jul; 134(7):728-33. PubMed ID: 27123562
[TBL] [Abstract][Full Text] [Related]
10. Vinyl sulfone analogs of lysophosphatidylcholine irreversibly inhibit autotaxin and prevent angiogenesis in melanoma.
Murph MM; Jiang GW; Altman MK; Jia W; Nguyen DT; Fambrough JM; Hardman WJ; Nguyen HT; Tran SK; Alshamrani AA; Madan D; Zhang J; Prestwich GD
Bioorg Med Chem; 2015 Sep; 23(17):5999-6013. PubMed ID: 26190462
[TBL] [Abstract][Full Text] [Related]
11. Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma.
Onken MD; Worley LA; Char DH; Augsburger JJ; Correa ZM; Nudleman E; Aaberg TM; Altaweel MM; Bardenstein DS; Finger PT; Gallie BL; Harocopos GJ; Hovland PG; McGowan HD; Milman T; Mruthyunjaya P; Simpson ER; Smith ME; Wilson DJ; Wirostko WJ; Harbour JW
Ophthalmology; 2012 Aug; 119(8):1596-603. PubMed ID: 22521086
[TBL] [Abstract][Full Text] [Related]
12. Blood biomarkers for uveal melanoma.
Triozzi PL; Singh AD
Future Oncol; 2012 Feb; 8(2):205-15. PubMed ID: 22335584
[TBL] [Abstract][Full Text] [Related]
13. Uveal melanoma: the inflammatory microenvironment.
Bronkhorst IH; Jager MJ
J Innate Immun; 2012; 4(5-6):454-62. PubMed ID: 22302072
[TBL] [Abstract][Full Text] [Related]
14. Autotaxin: its role in biology of melanoma cells and as a pharmacological target.
Jankowski M
Enzyme Res; 2011 Mar; 2011():194857. PubMed ID: 21423677
[TBL] [Abstract][Full Text] [Related]
15. An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma.
Onken MD; Worley LA; Tuscan MD; Harbour JW
J Mol Diagn; 2010 Jul; 12(4):461-8. PubMed ID: 20413675
[TBL] [Abstract][Full Text] [Related]
16. Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts.
David M; Wannecq E; Descotes F; Jansen S; Deux B; Ribeiro J; Serre CM; Grès S; Bendriss-Vermare N; Bollen M; Saez S; Aoki J; Saulnier-Blache JS; Clézardin P; Peyruchaud O
PLoS One; 2010 Mar; 5(3):e9741. PubMed ID: 20305819
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling of formalin-fixed paraffin embedded primary human uveal melanomas using DASL matrices.
Di Cesare S; Nantel A; Marshall JC; Fernandes BF; Antecka E; Orellana ME; Abourbih D; Saornil AM; Burnier MN
J Cancer Res Clin Oncol; 2010 Apr; 136(4):577-86. PubMed ID: 19823872
[TBL] [Abstract][Full Text] [Related]
18. Autotaxin.
Boutin JA; Ferry G
Cell Mol Life Sci; 2009 Sep; 66(18):3009-21. PubMed ID: 19506801
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of autotaxin predicts survival in uveal melanoma.
Singh AD; Sisley K; Xu Y; Li J; Faber P; Plummer SJ; Mudhar HS; Rennie IG; Kessler PM; Casey G; Williams BG
Br J Ophthalmol; 2007 Oct; 91(10):1385-92. PubMed ID: 17475713
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
